Investing.com - Financial Markets Worldwide

Vcanbio Cell & Gene Engineering Corp Ltd (600645)

Shanghai
Currency in CNY
27.22
-0.10(-0.37%)
Delayed Data·
600645 Scorecard
Full Analysis
Management has been aggressively buying back shares
600645 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
26.9128.17
52 wk Range
15.6028.20
Key Statistics
Edit
Bid/Ask
27.22 / 27.23
Prev. Close
27.32
Open
27.33
Day's Range
26.91-28.17
52 wk Range
15.6-28.2
Volume
19.84M
Average Volume (3m)
13.44M
1-Year Change
58.38%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600645 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 13
Holds more cash than debt on its balance sheet
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Vcanbio Cell & Gene Engineering Corp Ltd Company Profile

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, engages in the preparation and storage of cell detection tests in the People’s Republic of China. It offers cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. The company also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, genetic testing for drug safety guidance, disease genetic testing, and disease susceptibility testing for children and adults; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, it is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and synthetic agents; and in vitro diagnostic reagents and medical devices. The company was founded in 1992 and is based in Tianjin, the People’s Republic of China.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
2014
Market
China

Compare 600645 to Peers and Sector

Metrics to compare
600645
Peers
Sector
Relationship
P/E Ratio
142.7x−19.2x−0.5x
PEG Ratio
−7.100.330.00
Price/Book
3.5x7.8x2.6x
Price / LTM Sales
8.2x22.7x3.3x
Upside (Analyst Target)
-−0.7%40.3%
Fair Value Upside
Unlock−23.8%4.7%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.06 / --
Revenue / Forecast
350.79M / --
EPS Revisions
a
a
Unlock
Last 90 days

600645 Income Statement

FAQ

What Stock Exchange Does Vcanbio Cell Gene Engineering Trade On?

Vcanbio Cell Gene Engineering is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Vcanbio Cell Gene Engineering?

The stock symbol for Vcanbio Cell Gene Engineering is "600645."

What Is the Vcanbio Cell Gene Engineering Market Cap?

As of today, Vcanbio Cell Gene Engineering market cap is 12.46B.

What Is Vcanbio Cell Gene Engineering's Earnings Per Share (TTM)?

The Vcanbio Cell Gene Engineering EPS (TTM) is 0.19.

When Is the Next Vcanbio Cell Gene Engineering Earnings Date?

Vcanbio Cell Gene Engineering will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is 600645 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Vcanbio Cell Gene Engineering Stock Split?

Vcanbio Cell Gene Engineering has split 4 times.

How Many Employees Does Vcanbio Cell Gene Engineering Have?

Vcanbio Cell Gene Engineering has 2014 employees.

What is the current trading status of Vcanbio Cell Gene Engineering (600645)?

As of 14 Aug 2025, Vcanbio Cell Gene Engineering (600645) is trading at a price of 27.22, with a previous close of 27.32. The stock has fluctuated within a day range of 26.91 to 28.17, while its 52-week range spans from 15.60 to 28.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.